- Filed
- Nov 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Oct 15, 2025 | 396.97M sh |
| Capex | Q3 2025 · Sep 30, 2025 | $24.52M |
| Capex | Q3 2025 · Sep 30, 2024 | $6.9M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$249.84M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | −$279.68M |
| Short Term Investments | Q3 2025 · Sep 30, 2025 | $142.67M |
| Short Term Investments | Q3 2025 · Dec 31, 2024 | $208.09M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $158.13M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $115.69M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2024 | $164.19M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $702.29M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | $698.49M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $710.41M |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | $773.46M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $768.54M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $584.61M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $125.79M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $122.34M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $202.66M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $200.02M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $429.09M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $457.02M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $904.95M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $910.43M |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.25 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.94 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$0.28 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$1.03 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $34.56M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $115.92M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $39.34M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $109.95M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $75.17M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $229.07M |
| Rd Expense restated | Q3 2025 · Sep 30, 2024 | $67.04M |
| Rd Expense restated | Q3 2025 · Sep 30, 2024 | $205.22M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$91.25M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$319.07M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$83.54M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$293.62M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$94.9M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$329.9M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$89.07M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$308.7M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $38.48M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $130.07M |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $31.52M |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $55.46M |
| Revenue | Q3 2025 · Sep 30, 2025 | $67.46M |
| Revenue | Q3 2025 · Sep 30, 2025 | $176.73M |
| Revenue | Q3 2025 · Sep 30, 2024 | $58.56M |
| Revenue | Q3 2025 · Sep 30, 2024 | $90.38M |